by admin | Oct 2, 2025 | Announcements
At a glance Sansanima has closed a seed equity round to accelerate the rollout of human relevant, animal free testing for the manufacture of critical medicines and vaccine products. The round was supported by Sheffield Angels, o2h Ventures, and Cambridge Angels....
by admin | Aug 1, 2025 | Announcements
At a glance Our CEO Ciara Doran attended the Cambridge Angels networking event, engaging with investors and founders to discuss Sansanima’s plan to replace animal testing in the manufacture of critical medicines and vaccine products. Event highlights The event brought...
by admin | Jul 2, 2025 | Announcements, Publications & Media Mentions
At a glance Thank you to everyone who voted for our CEO and Co-founder, Dr Ciara Doran, in the ClimbUK Awards 2025. We are pleased to share that Ciara has been shortlisted as a top three finalist in the Emerging Talent of the Year category. About the shortlist ClimbUK...
by admin | Jun 2, 2025 | Announcements, Publications & Media Mentions
At a glance Our CEO, Dr Ciara Doran, has been nominated for the ClimbUK Emerging Talent of the Year Award in recognition of the rapid, positive progress being made at Sansanima. About the award ClimbUK describes this category as recognising an emerging talent who...
by admin | May 1, 2025 | Announcements
At a glance Sansanima joined the o2h Ventures chaitime portfolio pitch day at the Cambridge HQ, hosted by Sunil Shah. The event brought together promising early stage biotech companies to share progress with investors and partners. What we presented Our team outlined...
by admin | Jan 1, 2025 | Announcements, Publications & Media Mentions
At a glance The University of Sheffield profiled Sansanima Limited and our work to replace animal use in the manufacture and quality control of clostridial neurotoxin based medical products. CEO Ciara Doran explains how our cell based platform supports products such...
